Sergio Lociuro
Gründer bei THOT Consulting Sagl
Profil
Sergio Lociuro is the founder of THOT Consulting Sagl.
He currently works as a Director at Arpida A.
Previously, he worked as a Director-Medicinal Chemistry at GlaxoSmithKline AG, Head-Peptide Mimetics Business Unit at Spexis Ltd., Head-Research at Evolva Holding SA, Chief Scientific Officer at Caerus Consulting AS and Adenium Biotech ApS, and Manager-Research & Development at Sanofi-Aventis New Zealand Ltd.
He received his undergraduate degree from The American University of Rome in 1981 and his doctorate degree from the University of New Brunswick in 1987.
Aktive Positionen von Sergio Lociuro
| Unternehmen | Position | Beginn |
|---|---|---|
| THOT Consulting Sagl | Gründer | - |
| Arpida A/S | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Sergio Lociuro
| Unternehmen | Position | Ende |
|---|---|---|
| Sanofi-Aventis New Zealand Ltd. | Technik-/Wissenschafts-/F&E-Leiter | - |
| EVOLVA HOLDING SA | Technik-/Wissenschafts-/F&E-Leiter | - |
| SPEXIS AG | Corporate Officer/Principal | - |
Adenium Biotech ApS
 Adenium Biotech ApS Pharmaceuticals: MajorHealth Technology Adenium Biotech ApS develops and commercializes novel antibiotics for the treatment of multi drug resistant bacterial infections. It focuses on treatment of nosocomial infections, in particular complicated urinary tract infections and hospital or ventilator acquired pneumonia caused by multi drug resistant Gram-negative bacteria. The company offers Arenicin, an anti-microbial peptide against gram-negative pathogens for pneumonia, urinary tract infection, and acinetobacter baumanii. Adenium Biotech was founded by Peter Nordkild on August 24, 2011 and is headquartered in Copenhagen, Denmark. | Technik-/Wissenschafts-/F&E-Leiter | - |
GlaxoSmithKline AG
 GlaxoSmithKline AG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline AG is a Swiss company. | Corporate Officer/Principal | - |
Ausbildung von Sergio Lociuro
| The American University of Rome | Undergraduate Degree |
| University of New Brunswick | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SPEXIS AG | Health Technology |
| EVOLVA HOLDING SA | Consumer Non-Durables |
| Private Unternehmen | 6 |
|---|---|
| Arpida A/S | |
GlaxoSmithKline AG
GlaxoSmithKline AG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline AG is a Swiss company. | Health Technology |
Caerus Consulting AS
 Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway. | Health Technology |
Adenium Biotech ApS
Adenium Biotech ApS Pharmaceuticals: MajorHealth Technology Adenium Biotech ApS develops and commercializes novel antibiotics for the treatment of multi drug resistant bacterial infections. It focuses on treatment of nosocomial infections, in particular complicated urinary tract infections and hospital or ventilator acquired pneumonia caused by multi drug resistant Gram-negative bacteria. The company offers Arenicin, an anti-microbial peptide against gram-negative pathogens for pneumonia, urinary tract infection, and acinetobacter baumanii. Adenium Biotech was founded by Peter Nordkild on August 24, 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |
| THOT Consulting Sagl | |
| Sanofi-Aventis New Zealand Ltd. |
